ACTIVE

APOTHEEK ELSDONK

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result169,1 k €+25,9 %over 1 year
Gross margin284,6 k €+21,6 %over 1 year
Equity381,5 k €+22,1 %over 1 year
Workforce1,1 ETP+10,0 %over 1 year

Identity

Source · BCE/KBO

APOTHEEK ELSDONK is a Private limited company incorporated in 1997. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Antwerpen. It employs on average 1,1 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0460.956.569
Incorporation
27/06/1997
Legal form
Private limited company
Registered office
Prins Boudewijnlaan 340
2610 Antwerpen · FlandreSee on map
Contributed capital
18 592,01 €
Latest accounts
31/12/2025
Average workforce
1,1 ETP
Joint committees (2)
  • 313
  • 3130
Contacts
4 public details availableLog in to view
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 20 filings

Trend over 13 financial years

20252024202320222021
Income statement
Gross margin284,6 k €234 k €237,3 k €316,8 k €430,7 k €
EBITDA231,7 k €177,3 k €177,8 k €255,8 k €376,1 k €
Operating result227,5 k €174,3 k €162,5 k €229,7 k €348,6 k €
Net result169,1 k €134,3 k €131,7 k €160,7 k €244,8 k €
Balance sheet
Equity381,5 k €312,4 k €312,4 k €980,2 k €819,5 k €
Total assets655 k €732,6 k €602,4 k €1 M €1 M €
Cash207,8 k €146 k €353,6 k €862,5 k €168,9 k €
Debts272,5 k €400,7 k €289,1 k €63,3 k €208,4 k €
Other
Workforce1,1 ETP1,0 ETP1,0 ETP1,0 ETP1,0 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

4 active · 5 ended

Active mandates

Eline Vander Borght

Director · since 27 mars 2023

Active
Kristin Beatrijs Fraeyman

Director · since 27 mars 2023

Active
Apotheose

Director · since 31 décembre 2022 · 0794.425.842

Represented by Fraeyman Kristin

Active
Tiline Pharma

Director · since 31 décembre 2022 · 0794.425.941

Represented by Vander Borght Eline

Active

Ended mandates

Apotheose

Director · since 31 décembre 2022 · 0794.425.842

Represented by Fraeyman KRISTIN

Ended
Tiline Pharma

Director · since 31 décembre 2022 · 0794.425.941

Represented by Vander BORGHT ELINE

Ended
Kristiaan Slaets

Bestuurder

Ended
Kristiaan Slaets

Director

Ended

Other companies at this address

Prins Boudewijnlaan 340 2610 Antwerpen
CompanyCBE no.
De Nachtegaal● Active
0413.945.817
Pharmical● Active
0794.440.886

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date11/08/202626/06/202529/08/202430/08/202308/07/202229/07/2021
General meeting05/06/202606/06/202530/06/202402/06/202303/06/202204/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 20 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202505/06/202611/08/2026DutchPDF
Abridged model31/12/202406/06/202526/06/2025DutchPDF
Abridged model31/12/202330/06/202429/08/2024DutchPDF
Abridged model31/12/202202/06/202330/08/2023DutchPDF
Abridged model31/12/202103/06/202208/07/2022DutchPDF
Abridged model31/12/202004/06/202129/07/2021DutchPDF
Abridged model31/12/201905/06/202010/08/2020DutchPDF
Abridged model31/12/201807/06/201916/07/2019DutchPDF
Abridged model31/12/201701/06/201830/07/2018DutchPDF
Abridged model31/12/201602/06/201728/07/2017DutchPDF
Abridged model31/12/201503/06/201623/08/2016DutchPDF
Abridged model31/12/201405/06/201525/08/2015DutchPDF
Abridged model31/12/201306/06/201427/08/2014DutchPDF
Abridged model31/12/201207/06/201328/08/2013DutchPDF
Abridged model31/12/201101/06/201229/08/2012DutchPDF
Abridged model31/12/201003/06/201122/06/2011DutchPDF
Abridged model31/12/200904/06/201005/08/2010DutchPDF
Abridged model31/12/200805/06/200920/08/2009DutchPDF
Abridged model31/12/200706/06/200818/08/2008DutchPDF
Abridged model31/12/200601/06/200729/06/2007DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

4 active · 5 ended

Active mandates

Eline Vander Borght

Director · since 27 mars 2023

Active
Kristin Beatrijs Fraeyman

Director · since 27 mars 2023

Active
Apotheose

Director · since 31 décembre 2022 · 0794.425.842

Represented by Fraeyman Kristin

Active
Tiline Pharma

Director · since 31 décembre 2022 · 0794.425.941

Represented by Vander Borght Eline

Active

Ended mandates

Apotheose

Director · since 31 décembre 2022 · 0794.425.842

Represented by Fraeyman KRISTIN

Ended
Tiline Pharma

Director · since 31 décembre 2022 · 0794.425.941

Represented by Vander BORGHT ELINE

Ended
Kristiaan Slaets

Bestuurder

Ended
Kristiaan Slaets

Director

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates14/04/2023
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - WIJZIGING RECHTSVORM - BENAMING - ONTSLAGEN - BENOEMINGEN - ALGEMENE VERGADERING
    PDF
  • Mandates06/04/2023
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Capital / shares20/12/2017
    KAPITAAL - AANDELEN
    PDF
  • Other12/12/2013
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF
  • Registered office24/08/2004
    MAATSCHAPPELIJKE ZETEL - ALGEMENE VERGADERING - KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025169,1 k €↑
  2. 2024
    Annual accounts 2024134,3 k €↑
  3. 2023
    Annual accounts 2023131,7 k €↓
  4. 2022
    Annual accounts 2022160,7 k €↓
  5. 2022
    Name changeApotheek Elsdonk
  6. 2021
    Annual accounts 2021244,8 k €↑
  7. 2013
    Annual accounts 2013145,2 k €↓
  8. 2012
    Annual accounts 2012176,3 k €↑
  9. 2011
    Annual accounts 2011110,2 k €↓
  10. 2010
    Annual accounts 2010110,4 k €↑
  11. 2009
    Annual accounts 200996,6 k €↓
  12. 2008
    Annual accounts 2008101,2 k €↑
  13. 2007
    Annual accounts 200772,5 k €↑
  14. 2006
    Annual accounts 200656,6 k €
  15. 2006
    Name changeApotheek Slaets
  16. 27/06/1997
    IncorporationPrivate limited company